Laurion Capital Management LP Curis Inc Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $816,686 - $1.81 Million	-353,544 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.94 - $8.85 $49,551 - $63,189	7,140 Added 2.06%	353,544 $2.77 Million
Q2 2021 Aug 13, 2021	BUY	$7.45 - $16.27 $2.58 Million - $5.64 Million	346,404 New	346,404 $2.8 Million
Q1 2021 May 14, 2021	SELL	$8.78 - $12.8 $2.54 Million - $3.7 Million	-289,438 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$1.08 - $8.2 $312,593 - $2.37 Million	289,438 New	289,438 $2.37 Million
Q3 2018 Nov 13, 2018	SELL	$1.38 - $1.94 $42,090 - $59,170	-30,500 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$1.73 - $3.35 $52,765 - $102,175	30,500 New	30,500 $53,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $403M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.